[Tolerance of porous polyethylene orbital implants in children]

I Benatiya Andaloussi1, S Bhallil, M Abdellaoui

  • 1Service d'Ophtalmologie, CHU Hassan II, Fès, Maroc. cherdoc@hotmail.com

Insights

Porous polyethylene implants are effective for orbital reconstruction in children under 15. Implant exposure occurred in two cases, but overall, this method is appropriate with careful surgical technique.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Biomaterials

Context:

  • Orbital reconstruction after enucleation is crucial for pediatric patients.
  • Porous polyethylene implants offer a solution for orbital cavity restoration.
  • Understanding complication rates is vital for optimizing pediatric orbital implant use.

Purpose:

  • To determine the incidence of orbital complications following porous polyethylene implant insertion in children under 15.
  • To evaluate the safety and efficacy of porous polyethylene implants in pediatric anophthalmic cavity reconstruction.

Summary:

  • A series of 21 pediatric patients (under 15 years) received porous polyethylene implants for orbital reconstruction post-enucleation.
  • Over a mean follow-up of 23 months, two cases of implant extrusion were noted, primarily in retinoblastoma patients.
  • No instances of orbital cellulitis or anophthalmic syndrome were reported, indicating a generally favorable safety profile.

Impact:

  • Porous polyethylene implants are a suitable option for pediatric orbital reconstruction, with exposure being the main complication.
  • Highlights the importance of meticulous surgical technique to minimize risks associated with orbital implants in children.
  • Provides valuable data for ophthalmologists and surgeons managing pediatric enucleation and orbital reconstruction.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...